Athira Pharma Inc. (ATHA)

ATHA trades at $3.84, 668.0% above the near-term max pain of $0.5 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$2.5), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ATHA shows a downward trend from 2.5 to 0.5, indicating bearish sentiment or hedging activity. The 109% spread signals divergent expectations across timeframes. Most levels below 3.84 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.